임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
60건 표시 (상위 60건)
- 1상모집 중· Healthy SubjectsBioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
리드: 유한양행
- 2상모집 중· Primary Brain TumorBelvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
- 2상모집 중· Type 2 Diabetes MellitusStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
- 1/2상모집 중· Advanced Solid TumorsA First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
리드: 종근당
- 1상모집 중· Advanced Solid TumorsA Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
리드: 삼성바이오에피스
- 해당없음모집 중· Dyslipidemia Associated With Type II Diabetes MellitusModerate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
협력: 한미약품, 유한양행
- 2상모집 중· Advanced or Metastatic MelanomaBelvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
- 3상모집 중· Menorrhagiato Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
리드: JW중외제약
- 4상모집 중· Type 2 Diabetes Mellitus (T2DM)Glycemic Variability of Combination Therapies in T2DM
리드: JW중외제약
- 해당없음모집 중· HypertensionCART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension
협력: 대웅제약
- 1상모집 중· Advanced Solid TumorsPhase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
리드: 종근당
- 단계 미표기모집 중· Chronic Spontaneous Urticaria (CSU)ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
리드: 셀트리온
- 단계 미표기모집 중· Stage 1 HypertensionObservational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
리드: 대웅제약
- 1상모집 중· Healthy SubjectsPK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
리드: 대웅제약
- 단계 미표기모집 중· DyslipidemiasEfficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
리드: JW중외제약
- 단계 미표기모집 중· GastritisEfficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
리드: 대웅제약
- 1/2상모집 중· EGFR OverexpressionClinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
리드: 유한양행
- 1/2상모집 중· Tetanus-diphtheria-acellular Pertussis (Tdap)A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
리드: GC녹십자
- 1/2상모집 중· Fabry DisesaseA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
리드: GC녹십자 · 협력: 한미약품
- 4상모집 중· Coronary Artery DiseaseComparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
협력: 한미약품, 유한양행
- 단계 미표기모집 중· Crohn DiseaseROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
리드: 셀트리온
- 1/2상모집 중· Japanese Encephalitis Virus DiseaseA Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
리드: SK바이오사이언스
- 4상모집 중· Obesity and Type 2 DiabetesEffects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
협력: 대웅제약
- 4상모집 중· Type 2 DiabetesPioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
협력: 셀트리온
- 4상모집 중· Aortic Valve StenosisENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
협력: 대웅제약
- 1상모집 중· Advanced or Metastatic Solid TumorsDose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
- 3상모집 중· Parenteral NutritionClinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition
리드: 유한양행
- 단계 미표기모집 중· Diabetes Mellitus, Type 2Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
리드: 대웅제약
- 1상모집 중· Sanfilippo Syndrome Type APhase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
리드: GC녹십자
- 해당없음모집 중· Type 2 DiabetesA Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
협력: 셀트리온, 종근당, 대웅제약
- 해당없음모집 중· Acute Coronary Syndromes (ACS)Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy
협력: 대웅제약
- 해당없음모집 중· Ischemic StrokeOptimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
협력: 한미약품
- 1/2상모집 중· NSCLC (Non-small Cell Lung Cancer)A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
리드: 유한양행
- 1상모집 중· Healthy ParticipantsA First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants
리드: 유한양행
- 4상모집 중· Inflammatory Bowel DiseasesSubcutaneous Infliximab After A Previous Intravenous Dose Optimization
협력: 셀트리온
- 단계 미표기모집 중· Diabetes Mellitus, Type 2Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
리드: 종근당
- 3상모집 중· Relapsing-remitting Multiple SclerosisA Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
리드: 셀트리온
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.